| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 73 |
| 1 | SORAFENIB | 36 |
| 2 | SUNITINIB MALATE | 34 |
| 3 | CISPLATIN | 20 |
| 4 | CARBOPLATIN | 17 |
| 5 | AMLODIPINE | 16 |
| 6 | ADALIMUMAB | 15 |
| 7 | REGORAFENIB | 14 |
| 8 | DURVALUMAB | 13 |
| 9 | FUROSEMIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOXYBENZAMINE HYDROCHLORIDE | 1 | 0.0370 |
| 1 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 2 | ETHIODIZED OIL | 6 | 0.0046 |
| 3 | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0037 |
| 4 | TREMELIMUMAB | 11 | 0.0025 |
| 5 | PLATINUM | 1 | 0.0019 |
| 6 | SORAFENIB | 36 | 0.0017 |
| 7 | FILGRASTIM-AAFI | 1 | 0.0015 |
| 8 | AIRBORNE | 1 | 0.0015 |
| 9 | DACTINOMYCIN | 3 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 110 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 82 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 75 |
| 3 | Platinum-based Drug [EPC] | 45 |
| 4 | Corticosteroid [EPC] | 27 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 20 |
| 7 | Insulin Analog [EPC] | 18 |
| 8 | Alkylating Drug [EPC] | 17 |
| 9 | Calcium Channel Blocker [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 3 | 0.0014 |
| 1 | Non-Standardized House Dust Allergenic Extract [EPC] | 1 | 0.0013 |
| 2 | Standardized Animal Hair Allergenic Extract [EPC] | 1 | 0.0012 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 82 | 0.0008 |
| 6 | Interferon gamma [EPC] | 1 | 0.0007 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 13 | 0.0006 |
| 8 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 75 | 0.0004 |